Key result
Hypoxic MSC exosomes boost post-MI survival, shrink scar size, and improve cardiac recovery in mice.
Why the study?
Hypoxia treatment enhances the paracrine effect of mesenchymal stem cells, prompting investigation into whether exosomes from hypoxia-treated mesenchymal stem cells are superior to those from normoxia-treated mesenchymal stem cells for myocardial repair.
Do exosomes derived from hypoxia-treated mesenchymal stem cells improve myocardial repair and cardiac function recovery compared to exosomes from normoxia-treated mesenchymal stem cells in a mouse model of myocardial infarction?
Do exosomes derived from hypoxia-treated mesenchymal stem cells improve myocardial repair and cardiac function recovery compared to exosomes from normoxia-treated mesenchymal stem cells in a mouse model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
Hypoxic preconditioning of mesenchymal stem cells for 24 hours enhances the cardioprotective and reparative efficacy of their secreted exosomes in infarcted mouse hearts through nSMase2-dependent enrichment and transfer of miR-210.
Hypoxia treatment enhances paracrine effect of mesenchymal stem cells (MSCs). The aim of this study was to investigate whether exosomes from hypoxia-treated MSCs (ExoH) are superior to those from normoxia-treated MSCs (ExoN) for myocardial repair. Mouse bone marrow-derived MSCs were cultured under hypoxia or normoxia for 24 h, and exosomes from conditioned media were intramyocardially injected into infarcted heart of C57BL/6 mouse. ExoH resulted in significantly higher survival, smaller scar size and better cardiac functions recovery. ExoH conferred increased vascular density, lower cardiomyocytes (CMs) apoptosis, reduced fibrosis and increased recruitment of cardiac progenitor cells in the infarcted heart relative to ExoN. MicroRNA analysis revealed significantly higher levels of microRNA-210 (miR-210) in ExoH compared with ExoN. Transfection of a miR-210 mimic into endothelial cells (ECs) and CMs conferred similar biological effects as ExoH. Hypoxia treatment of MSCs increased the expression of neutral sphingomyelinase 2 (nSMase2) which is crucial for exosome secretion. Blocking the activity of nSMase2 resulted in reduced miR-210 secretion and abrogated the beneficial effects of ExoH. In conclusion, hypoxic culture augments miR-210 and nSMase2 activities in MSCs and their secreted exosomes, and this is responsible at least in part for the enhanced cardioprotective actions of exosomes derived from hypoxia-treated cells.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2017) studied Myocardial infarction in C57BL/6 mice. Intramyocardial injection of exosomes from 24-hour hypoxia-treated mesenchymal stem cells (ExoH) vs. Intramyocardial injection of exosomes from 24-hour normoxia-treated mesenchymal stem cells (ExoN) was evaluated on Survival, scar size, and cardiac function recovery. Exosomes from 24-h hypoxia-treated MSCs significantly improved survival, reduced scar size, and enhanced cardiac function recovery compared with normoxic MSC exosomes in infarcted mice.
Synapse has enriched 10 related papers. Consider them for comparative context: